Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4509898)

Published in J Int AIDS Soc on July 20, 2015

Authors

Ide Cremin1, Fernando Morales2, Britta L Jewell3, Kevin R O'Reilly4, Timothy B Hallett3

Author Affiliations

1: Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom; ide.cremin05@imperial.ac.uk.
2: ICAP Columbia University, New York, NY, USA.
3: Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
4: World Health Organization, Geneva, Switzerland.

Articles cited by this

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet (2014) 3.88

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr (2014) 2.43

Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med (2013) 1.98

The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81

Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples. Epidemiology (2013) 1.54

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet (2014) 1.49

Use of antiretrovirals for HIV prevention: what do we know and what don't we know? Curr HIV/AIDS Rep (2013) 1.49

The determinants of HIV treatment costs in resource limited settings. PLoS One (2012) 1.47

Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS (2013) 1.10

Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther (2012) 1.02

HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99

HIV prevalence and incidence in a cohort of women at higher risk for HIV acquisition in Chókwè, southern Mozambique. PLoS One (2014) 0.91

Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial. BMC Infect Dis (2012) 0.84

Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for? Expert Rev Pharmacoecon Outcomes Res (2014) 0.80

Population movements and the spread of HIV/AIDS in Mozambique. J Health Hum Serv Adm (2001) 0.78